SIG
CDMO

Sargent Investment Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Sargent Investment Group’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-377,694
Closed -$4.69M – 250
2024
Q4 		$4.69M Sell
377,694
-180,936
-32% -$2.07M 0.77% 32
2024
Q3 		$6.36M Sell
558,630
-37,350
-6% -$375K 1.14% 22
2024
Q2 		$4.26M Sell
595,980
-94,475
-14% -$723K 0.87% 30
2024
Q1 		$4.63M Sell
690,455
-22,050
-3% -$152K 1.01% 26
2023
Q4 		$4.63M Sell
712,505
-8,456
-1% -$54.5K 1.01% 27
2023
Q3 		$6.81M Sell
720,961
-11,900
-2% -$143K 1.64% 17
2023
Q2 		$10.2M Sell
732,861
-12,944
-2% -$221K 2.49% 10
2023
Q1 		$14M Sell
745,805
-19,291
-3% -$317K 3.69% 3
2022
Q4 		$10.5M Buy
765,096
+22,850
+3% +$350K 3.27% 3
2022
Q3 		$13.8M Sell
742,246
-11,640
-2% -$212K 4.31% 2
2022
Q2 		$11.5M Buy
753,886
+960
+0.1% +$14.2K 3.56% 2
2022
Q1 		$15.3M Sell
752,926
-15,801
-2% -$322K 3.87% 4
2021
Q4 		$22.4M Sell
768,727
-43,386
-5% -$1.24M 5.12% 2
2021
Q3 		$17.5M Sell
812,113
-35,850
-4% -$865K 4.26% 3
2021
Q2 		$21.8M Sell
847,963
-29,419
-3% -$628K 5.16% 2
2021
Q1 		$16M Sell
877,382
-49,967
-5% -$830K 4.21% 4
2020
Q4 		$10.7M Sell
927,349
-124,750
-12% -$1.14M 3.38% 6
2020
Q3 		$8.02M Sell
1,052,099
-11,000
-1% -$83.3K 2.92% 11
2020
Q2 		$7.58M Sell
1,063,099
-102,898
-9% -$574K 2.85% 10
2020
Q1 		$5.96M Buy
1,165,997
+204,415
+21% +$1.24M 2.74% 11
2019
Q4 		$7.38M Buy
961,582
+324,471
+51% +$1.89M 2.71% 9
2019
Q3 		$3.38M Buy
637,111
+23,678
+4% +$147K 1.52% 19
2019
Q2 		$3.44M Buy
613,433
+13,700
+2% +$56.5K 1.57% 19
2019
Q1 		$2.55M Buy
599,733
+45,099
+8% +$184K 1.23% 21
2018
Q4 		$2.27M Buy
+554,634
New +$2.89M 1.4% 20

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sargent Investment Group's CDMO Position: Q1 2025 in Review

Sargent Investment Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 377,694 shares — an estimated $4.69M sold.

Sargent Investment Group first reported a position in CDMO in Q4 2018 and held it in 25 quarters. The position peaked at $22.4M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Sargent Investment Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Sargent Investment Group sold 377,694 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $4.69M.
  • Sargent Investment Group first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2018 and held it in 25 quarters.
  • Sargent Investment Group's Avid Bioservices, Inc. Common Stock position peaked at $22.4M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Sargent Investment Group's 13F filing for Q1 2025, filed 5 May 2025.